A.B. (André) Rietman, PhD

I work as a mental health-/neuro-psychologist at the departments of Child and Adolescent Psychology/Psychiatry (CAPP) and Surgery of the Erasmus MC- Sophia Children's Hospital, within the outpatient team for children with developmental disorders and their families. I am involved in long-running follow-up programs such as VOLG (early recognition of learning and behavioural problems in children with genetic disorders) and CHIL (surgical long-term follow-up).

My research focuses on behavior and learning in children with genetic or inborn rare conditions. For this I cooperate with Centre for Expertise ENCORE, European reference network ERNICA, and European Patient Platform EURORDIS.

• Behavioral phenotype of rare conditions
• Clinical Neuropsychology and cognitive outcomes
• Patient Reported Outcomes (PROMs)
• Sensory Processing

I studied occupational therapy in Amsterdam (1986), psychology in Leiden (1997) and (child) neuropsychology in Amsterdam (2000) and obtained my PhD at Erasmus MC in Rotterdam (2019).

As an assistant professor, I supervise PhD students, master-students; master psychologists, mental health psychologists, clinical psychologists, and clinical neuropsychologists in training.

I work at the overarching Quality of Life working group of ERNICA, the Steering Group, and the Mental Health Research group within EURORDIS.

I received grants from Fonds Nuts Ohra, Pierre Fabre pharmaceuticals, and Stichting Hartekind.

Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1.
Ottenhoff MJ, Rietman AB, Mous SE, Plasschaert E, Gawehns D, Brems H, Oostenbrink R; ENCORE-NF1 Team, van Minkelen R, Nellist M, Schorry E, Legius E, Moll HA, Elgersma Y. (2020). Genet Med. 2020 Feb 4.

An overview of health issues and development in a large clinical cohort of children with Angelman syndrome.
Bindels-de Heus KGCB, Mous SE, Ten Hooven-Radstaake M, van Iperen-Kolk BM, Navis C, Rietman AB, Ten Hoopen LW, Brooks AS; ENCORE Expertise Center for AS, Elgersma Y, Moll HA, de Wit M. (2020). Am J Med Genet A. 2020 Jan;182(1):53-63. 

A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex. Neurology.
Overwater IE, Rietman AB, Mous SE, Bindels-de Heus K, Rizopoulos D, ten Hoopen LW, van der Vaart T,  Jansen FE, Elgersma Y, Moll HA, de Wit MCY on behalf of the ENCORE Expertise Centre for Neurodevelopmental Disorders. (2019). Neurology. 2019 Jul 9;93(2):e200-e209.

Omphalocele at school age: What do parents report? A call for long-term follow-up of complex omphalocele patients.
Hijkoop A, Rietman AB, Wijnen RMH, Tibboel D, Cohen-Overbeek TE, van Rosmalen J, IJsselstijn H. (2019). Early Hum Dev. 2019 Oct;137.

Everolimus for the treatment of refractory seizures associated with tuberous sclerosis complex (TSC): current perspectives.
Overwater IE, Rietman AB, van Eeghen AM, de Wit MCY (2019). Ther Clin Risk Manag. 2019 Jul 26;15:951-955. Review.

Find more on: 

• ResearchGate
• Google Scholar
• PubMed
• SCOPUS
• Pure